Cited 24 times in
Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김준원 | - |
dc.contributor.author | 김혜련 | - |
dc.contributor.author | 서양권 | - |
dc.contributor.author | 이창걸 | - |
dc.contributor.author | 조병철 | - |
dc.contributor.author | 조재호 | - |
dc.contributor.author | 최치환 | - |
dc.date.accessioned | 2017-02-24T03:23:35Z | - |
dc.date.available | 2017-02-24T03:23:35Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 1533-0346 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/146333 | - |
dc.description.abstract | In this study, the volume response and treatment outcome after hippocampus-sparing whole-brain radiotherapy (HS-WBRT) with simultaneous integrated boost (SIB) using tomotherapy were evaluated. Patients with primary lung adenocarcinoma and multiple brain metastases who had a Karnofsky performance status ≥ 70 and exhibited well-controlled extracranial disease were treated. The prescribed dose was administered in 10 to 14 fractions as 25 to 28 Gy to whole-brain parenchyma, as 40 to 48 Gy to the gross metastatic lesion, and as 30 to 42 Gy to a 5-mm margin to the metastatic lesion. Double-dose gadolinium contrast-enhanced magnetic resonance imaging at 1-mm slice thickness was performed before treatment and at 1, 4, and 7 months post-treatment. The tumor volume reduction ratio was calculated for each follow-up. Between July 2011 and September 2012, 11 patients with 70 lesions were included in this analysis. The median number of lesions per patient was 4 (range, 2-15). The median initial tumor volume was 0.235 cm(3) (range, 0.020-10.140 cm(3)). The treatment plans were evaluated regarding conformation number (CN), target coverage (TC), and homogeneity index (HI). The median follow-up duration was 14 months (range, 3-25 months) and the 1-year intracranial control rate was 67%. The tumor volume reduction was most prominent during the first month with a median reduction rate of 0.717 (range, -0.190 to 1.000). Complete remission was seen in 22 (33%) lesions, and 45 (64%) lesions showed more than 65% reduction in tumor volume. The CN, TC, and HI values were comparable to that of previous studies, and the mean hippocampal dose was 13.65 Gy. No treatment breaks or ≥ G3 acute toxicities were observed during or after treatment. The HS-WBRT with SIB in patients with multiple brain metastases was effective and feasible for volume reduction and showed excellent intracranial control. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.format.extent | 122~129 | - |
dc.language | English | - |
dc.publisher | SAGE | - |
dc.relation.isPartOf | TECHNOLOGY IN CANCER RESEARCH & TREATMENT | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adenocarcinoma/mortality | - |
dc.subject.MESH | Adenocarcinoma/radiotherapy* | - |
dc.subject.MESH | Adenocarcinoma/secondary | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Aged, 80 and over | - |
dc.subject.MESH | Brain Neoplasms/mortality | - |
dc.subject.MESH | Brain Neoplasms/radiotherapy* | - |
dc.subject.MESH | Brain Neoplasms/secondary | - |
dc.subject.MESH | Dose Fractionation | - |
dc.subject.MESH | Dose-Response Relationship, Radiation | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Hippocampus/pathology | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Kaplan-Meier Estimate | - |
dc.subject.MESH | Lung Neoplasms/mortality | - |
dc.subject.MESH | Lung Neoplasms/pathology | - |
dc.subject.MESH | Lung Neoplasms/radiotherapy* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Organ Sparing Treatments | - |
dc.subject.MESH | Radiotherapy Planning, Computer-Assisted | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Treatment Outcome | - |
dc.subject.MESH | Tumor Burden/radiation effects | - |
dc.title | Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation. | - |
dc.type | Article | - |
dc.publisher.location | United States | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Radiation Oncology | - |
dc.contributor.googleauthor | Kyung Hwan Kim | - |
dc.contributor.googleauthor | Byoung Chul Cho | - |
dc.contributor.googleauthor | Chang Geol Lee | - |
dc.contributor.googleauthor | Hye Ryun Kim | - |
dc.contributor.googleauthor | Yang Gun Suh | - |
dc.contributor.googleauthor | Jun Won Kim | - |
dc.contributor.googleauthor | Chihwan Choi | - |
dc.contributor.googleauthor | Jong Geal Baek | - |
dc.contributor.googleauthor | Jaeho Cho | - |
dc.identifier.doi | 10.1177/1533034614566993 | - |
dc.contributor.localId | A00958 | - |
dc.contributor.localId | A01166 | - |
dc.contributor.localId | A01891 | - |
dc.contributor.localId | A03240 | - |
dc.contributor.localId | A03822 | - |
dc.contributor.localId | A03901 | - |
dc.contributor.localId | A04203 | - |
dc.relation.journalcode | J02714 | - |
dc.identifier.eissn | 1533-0338 | - |
dc.identifier.pmid | 25601853 | - |
dc.identifier.url | http://tct.sagepub.com/content/15/1/122.long | - |
dc.subject.keyword | brain metastasis | - |
dc.subject.keyword | hippocampus | - |
dc.subject.keyword | lung adenocarcinoma | - |
dc.subject.keyword | radiotherapy | - |
dc.subject.keyword | tumor volume | - |
dc.contributor.alternativeName | Kim, Jun Won | - |
dc.contributor.alternativeName | Kim, Hye Ryun | - |
dc.contributor.alternativeName | Suh, Yang Gun | - |
dc.contributor.alternativeName | Lee, Chang Geol | - |
dc.contributor.alternativeName | Cho, Byoung Chul | - |
dc.contributor.alternativeName | Cho, Jae Ho | - |
dc.contributor.alternativeName | Choi, Chi Hwan | - |
dc.contributor.affiliatedAuthor | Kim, Jun Won | - |
dc.contributor.affiliatedAuthor | Kim, Hye Ryun | - |
dc.contributor.affiliatedAuthor | Suh, Yang Gun | - |
dc.contributor.affiliatedAuthor | Lee, Chang Geol | - |
dc.contributor.affiliatedAuthor | Cho, Byoung Chul | - |
dc.contributor.affiliatedAuthor | Cho, Jae Ho | - |
dc.contributor.affiliatedAuthor | Choi, Chi Hwan | - |
dc.citation.volume | 15 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 122 | - |
dc.citation.endPage | 129 | - |
dc.identifier.bibliographicCitation | TECHNOLOGY IN CANCER RESEARCH & TREATMENT, Vol.15(1) : 122-129, 2016 | - |
dc.date.modified | 2017-02-24 | - |
dc.identifier.rimsid | 53140 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.